Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.

by Anna Azvolinsky

Cancer patients and survivors share tips for coping with the uncertainty and isolation brought on by the coronavirus, and the coronavirus is impacting cancer clinical trials and treatment.

by Kate Yandell and Marci A. Landsmann

The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

by Anna Azvolinsky

A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.

by Marci A. Landsmann

The spread of the coronavirus is having an impact on cancer care, and the Food and Drug Administration will require cigarette packaging and advertisements to come with new graphic warning labels.

by Kate Yandell

Cancer patients in the U.S. are feeling impacts from the new coronavirus.

by Kate Yandell

Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

by Ashley P. Taylor

Experts offer information and cancer centers take precautions in light of the novel coronavirus, and the Food and Drug Administration approves an immunotherapy combination for liver cancer.

by Kate Yandell

A report shows that colorectal cancer incidence is decreasing in older adults while simultaneously rising in younger individuals, and the Food and Drug Administration approves a new treatment for multiple myeloma.

by Kate Yandell

Using an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.

by Kate Yandell